Stock Market Today With IBD Market Fades From Highs; Eli Lilly, Google, Bloom Energy In Focus
Jan 7, 2026
Ken Shreve and Ed Carson dive into the day's market movements, highlighting the Dow's struggles amidst a mixed session. They discuss growth stock leadership as the NASDAQ shows resilience despite challenges in various sectors. Eli Lilly shines with a breakout linked to obesity drug prospects, while Alphabet gains traction from its AI developments, surpassing Apple in market cap. Bloom Energy's volatility and partnership with Oracle also generate interest, offering intriguing prospects for traders.
AI Snips
Chapters
Transcript
Episode notes
Market Pullback Masks Continuing Strength
- The market showed a mixed session with major indexes pulling back after recent highs. Growth stocks and many leaders remain strong despite weaker underlying breadth.
Biotech Rally Ahead Of Conference
- Biotech showed strong rotation and big ETF gains, anticipating event-driven moves. The JP Morgan Healthcare Conference may trigger further volatility and individual winners or losers.
Software Group Still Shows Damage
- Software names carry noticeable damage with many still below key moving averages. Select winners exist but the group has several broken leaders needing stronger bases.